There is trust in [Colombia], and regardless of which shade of government is in power, we will not stop investing in its future
In Conversation
LatAm has an ethnically diverse population, strong doctor-patient relationships, and great clinical research centres, all of which are increasingly attracting the eye of our member companies…
"In our 69 years in this market, we have managed to establish a leading position in the areas of cancer treatment, immunology, hepatitis C and virology"
"Colombian pharmaceutical firms are very focssed on the early treatment of patients and medical education campaigns that are beginning to spread across the region."
"As a pioneer in diagnostics, bioMérieux’s mission consists in improving public health worldwide."
"Having successfully made an entry to Europe, Asia and Latin America, JSS is now a full-service international CRO. As of today, the company counts more than…
"The key to success in the Colombian market is access. Some of our products, such as diabetes related treatments, are included in the public health national…
"We are selective when it comes to our internationalisation strategy. Our priority is to make sure the products have a good regulatory fit with the country."
Felipe Jaramillo, president at ProColombia, the government agency in charge of strengthening the country’s image, describes how Colombia successfully transitioned from being a war-damaged country to…
"We believe collaboration with institutions serves as fundamental to building a strong presence in [Colombia]"
"[Aspen] has the strong wish to work closely with the government, especially in order to help augment its efficiency in the pharmaceutical field."
"As the market is experiencing frequent regulatory changes, the requirements have transformed, necessitating an alteration in the way we approach the market."
